Abstract
In this issue of Blood, Sanders and coworkers define the pathophysiology of types 1, 2, and 3 von Willebrand disease (VWD) in the Willebrand in the Netherlands (WiN) study by using the ratios of von Willebrand factor propeptide (VWFpp) or factor VIII activity to VWF antigen.
Cite
CITATION STYLE
APA
Haberichter, S. L. (2015, May 7). VWF propeptide in defining VWD subtypes. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2015-03-629832
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free